Bide Pharmatech Co., Ltd. (SHA:688073)
China · Delayed Price · Currency is CNY 58.82
+1.21 (2.10%)
At close: Oct 23, 2026
Bide Pharmatech Revenue
Bide Pharmatech had revenue of 359.56M CNY in the quarter ending June 30, 2026, with 8.58% growth. This brings the company's total for the last twelve months to 1.38B, up 15.18% year-over-year. In the year 2025, Bide Pharmatech had annual revenue of 1.32B with 20.13% growth. That makes Bide Pharmatech the 17,242nd largest company in the world by revenue and 3,122nd in China.
Revenue (ttm)
1.38B
Revenue Growth
+15.18%
P/S Ratio
3.67
Revenue / Employee
1.88M
Employees
734
Market Cap
5.07B
Revenue by Geography
- Overseas 759.27M 57.4%
- China 564.53M 42.6%
Fiscal year ended Dec 31, 2025 See the full Bide Pharmatech breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.32B | 221.80M | 20.13% |
| Dec 31, 2024 | 1.10B | 10.15M | 0.93% |
| Dec 31, 2023 | 1.09B | 258.03M | 30.94% |
| Dec 31, 2022 | 833.83M | 227.61M | 37.55% |
| Dec 31, 2021 | 606.22M | 214.75M | 54.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.